Literature DB >> 28949096

Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors.

Abhijit S Naik1, Diane M Cibrik1, Ankit Sakhuja2, Milagros Samaniego1, Yee Lu1, Vahakn Shahinian1, Silas P Norman1, Mark A Schnitzler3, Bertram L Kasiske4,5, Dorry L Segev6, Krista L Lentine3.   

Abstract

The impact of pre-donation obesity on long-term outcomes of living kidney donors remains controversial. Published guidelines offer varying recommendations regarding BMI (kg/m2 ) thresholds for donor acceptance. We examined temporal and center-level variation in BMI of accepted donors across US transplant centers. Using national transplant registry data, we performed multivariate hierarchical logistic regression modeling using pairwise comparisons (overweight, BMI: 25-29.9; mildly obese, BMI: 30-34.9; very obese, BMI: ≥35; versus normal BMI: 18.5-24.9). Metrics of heterogeneity, including median odds ratio (MOR), were calculated. Among 90 013 living kidney donors, 2001-2016, proportions who were very obese decreased and proportions who were mildly obese or overweight increased. Significant center-level heterogeneity was noted in BMI of accepted donors; the MOR varied from 1.10 for overweight to 1.93 for very obese donors. At centers located in the 10 states with the highest general population obesity rates, adjusted odds of very obese donor status were 185% higher (reference: normal BMI) than in states with the lowest obesity rates. Although there is a declining trend in acceptance of very obese living kidney donors, variation across centers is significant. Furthermore, local population obesity rates may affect the decision to accept obese individuals as donors.
© 2017 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research; kidney transplantation: living donor; nephrology; obesity; practice

Mesh:

Year:  2017        PMID: 28949096     DOI: 10.1111/ajt.14519

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  5 in total

1.  Associations of obesity with antidiabetic medication use after living kidney donation: An analysis of linked national registry and pharmacy fill records.

Authors:  Krista L Lentine; Farrukh M Koraishy; Nagaraju Sarabu; Abhijit S Naik; Ngan N Lam; Amit X Garg; David Axelrod; Zidong Zhang; Gregory P Hess; Bertram L Kasiske; Dorry L Segev; Macey L Henderson; Allan B Massie; Courtenay M Holscher; Mark A Schnitzler
Journal:  Clin Transplant       Date:  2019-09-08       Impact factor: 2.863

2.  Obesity and long-term mortality risk among living kidney donors.

Authors:  Jayme E Locke; Rhiannon D Reed; Allan B Massie; Paul A MacLennan; Deirdre Sawinski; Vineeta Kumar; Jon J Snyder; Alexis J Carter; Brittany A Shelton; Margaux N Mustian; Cora E Lewis; Dorry L Segev
Journal:  Surgery       Date:  2019-05-07       Impact factor: 3.982

3.  Intermediate Renal Outcomes, Kidney Failure, and Mortality in Obese Kidney Donors.

Authors:  Hassan N Ibrahim; Dina N Murad; Sean A Hebert; Horacio E Adrogue; Hana Nguyen; Duc T Nguyen; Arthur J Matas; Edward A Graviss
Journal:  J Am Soc Nephrol       Date:  2021-10-21       Impact factor: 10.121

4.  Early Hypertension and Diabetes After Living Kidney Donation: A National Cohort Study.

Authors:  Courtenay M Holscher; Sunjae Bae; Alvin G Thomas; Macey L Henderson; Christine E Haugen; Sandra R DiBrito; Abimereki D Muzaale; Jacqueline M Garonzik Wang; Allan B Massie; Krista L Lentine; Dorry L Segev
Journal:  Transplantation       Date:  2019-06       Impact factor: 4.939

5.  Concerns and Challenges of Living Donors When Making Decisions on Organ Donation: A Qualitative Study.

Authors:  Raziyeh Sadat Bahador; Jamileh Farokhzadian; Parvin Mangolian; Esmat Nouhi
Journal:  Iran J Nurs Midwifery Res       Date:  2022-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.